top news
05.03.2015, 15:06
OREANDA-NEWS. Chimpharm JSC (Shymkent, hereinafter – the
Company), whose securities are officially listed on Kazakhstan Stock Exchange
(KASE), has by an official letter informed KASE that "the Board of Directors of
Chimpharm JSC decided to buy 8,900 registered coupon bonds of Chimpharm
JSC NIN KZ2C0Y05E370 from holder Visor Capital JSC for the acquisition price
of KZT1,019.8 (one thousand nineteen tenge and eighty tiyn) with a coupon
payout on the day of the transaction.".
Rate this article:
Комментарии